Get the Stockscreener App
1.90
4.52%
-0.09
After Hours:
1.90
Immuneering Corp Stock (IMRX) Forecast
The Immuneering Corp (IMRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.35, representing a +444.58% increase from the current price of $1.90. The highest analyst price target is $9.9889, and the lowest is $10.71.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMRX Price Target
Average 5.0308
(+164.78% Upside)
Is Immuneering Corp (IMRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.20 | Neutral |
| STOCH(9,6) | 24.92 | Neutral |
| STOCHRSI(14) | 19.47 | Buy |
| MACD(12,26) | -0.0418 | Sell |
| ADX(14) | 29.47 | Buy |
| William %R | -87.14 | Buy |
| CCI(14) | -52.84 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.9235
Sell
|
1.9471
Sell
|
| MA20 |
1.9793
Sell
|
1.9831
Sell
|
| MA50 |
2.0476
Sell
|
2.016
Sell
|
| MA100 |
2.1361
Sell
|
2.0207
Sell
|
| MA200 |
1.733
Buy
|
2.5559
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, IMRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on IMRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.2 indicates that IMRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.92 indicates that IMRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.47 indicates that IMRX is oversold. This suggests that IMRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.47 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -52.84 indicates that IMRX is still oversold but not to an extreme extent.
Long-term IMRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immuneering Corp financial reports and earnings history, Immuneering Corp (IMRX) stock could reach $44.58 by 2030, $66.49 by 2040 and $204.90 by 2050. See the projected annual prices until 2050 of the Immuneering Corp stock below:
- Immuneering Corp (IMRX) is expected to reach an average price of $17.65 in 2035, with a high prediction of $19.41 and a low estimate of $19.87. This indicates an $828.89% rise from the last recorded price of $1.90.
- Immuneering Corp (IMRX) stock is projected to chart a bullish course in 2040, with an average price target of $60.90, representing an $3,105% surge from its current level. The forecast ranges from a conservative $61.96 to a sky-high $66.49.
- Our analysts predict Immuneering Corp (IMRX) to jump 6,568% by 2045, soaring from $127.42 to an average price of $126.69, potentially reaching $129.73. While $127.42 is the low estimate, the potential upside is significant.
- Immuneering Corp (IMRX) stock is expected to climb by 2050, reaching an average of $206.45, a $10,766% jump from its current level. However, a wide range of estimates exists, with high and low targets of $204.90 and $207.20, respectively, highlighting the market's uncertainty.
Immuneering Corp Stock (IMRX) Year by Year Forecast
Immuneering Corp Stock (IMRX) Price Forecast for 2025
Immuneering Corp Stock (IMRX) is expected to reach an average price of $6.6583 in 2025, with a high prediction of $13.28 and a low estimate of $0.0344. This indicates an +250.44% rise from the last recorded price of $1.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $10.50 | $10.71 | $9.9889 | +452.37% |
| April, 2025 | $5.5354 | $5.9554 | $10.03 | +191.34% |
| May, 2025 | $2.2237 | $3.2887 | $1.3174 | +17.03% |
| June, 2025 | $7.0319 | $1.8877 | $4.0919 | +270.10% |
| July, 2025 | $8.6823 | $8.0381 | $7.4823 | +356.96% |
| August, 2025 | $9.3305 | $9.3785 | $8.5765 | +391.08% |
| September, 2025 | $8.4888 | $8.5488 | $8.5447 | +346.78% |
| October, 2025 | $7.0491 | $7.2391 | $8.2634 | +271.01% |
| November, 2025 | $0.9774 | $4.0224 | $6.0612 | -48.56% |
| December, 2025 | $0.3723 | $0.0344 | $3.5344 | -80.41% |
Immuneering Corp Stock (IMRX) Price Forecast for 2026
The predicted value for Immuneering Corp (IMRX) in 2026 is set at an average of $2.3931. Estimates vary from a peak of $4.7648 to a trough of $0.0214, indicating an +25.95% surge from the present price of $1.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.531 | $2.5939 | $2.1218 | +85.84% |
| February, 2026 | $1.7858 | $0.6242 | $2.068 | -6.01% |
| March, 2026 | $1.0675 | $0.1875 | $2.6437 | -43.82% |
| April, 2026 | $2.0572 | $0.3964 | $2.7492 | +8.27% |
| May, 2026 | $1.4989 | $0.5151 | $2.453 | -21.11% |
| June, 2026 | $0.7706 | $0.2527 | $2.0906 | -59.44% |
| July, 2026 | $0.8603 | $0.0214 | $1.1386 | -54.72% |
| August, 2026 | $2.122 | $0.1318 | $2.407 | +11.69% |
| September, 2026 | $2.1617 | $0.69 | $3.7558 | +13.77% |
| October, 2026 | $1.6634 | $1.3134 | $3.2296 | -12.45% |
| November, 2026 | $2.9552 | $1.4372 | $3.1252 | +55.53% |
| December, 2026 | $3.6448 | $2.4281 | $4.7648 | +91.83% |
Immuneering Corp Stock (IMRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immuneering Corp (IMRX) is $16.92, with a high forecast of $33.68 and a low forecast of $0.1534. This indicates an +790.36% increase from the last price of $1.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1334 | $0.1534 | $3.8828 | -92.98% |
| February, 2027 | $0.3117 | $0.2455 | $0.1517 | -83.59% |
| March, 2027 | $26.40 | $0.2038 | $21.69 | +1,290% |
| April, 2027 | $28.42 | $25.31 | $24.06 | +1,396% |
| May, 2027 | $33.41 | $30.36 | $30.85 | +1,658% |
| June, 2027 | $34.08 | $33.33 | $33.39 | +1,693% |
| July, 2027 | $33.74 | $34.35 | $33.68 | +1,676% |
| August, 2027 | $32.49 | $32.63 | $32.80 | +1,610% |
| September, 2027 | $33.05 | $33.28 | $32.60 | +1,639% |
| October, 2027 | $32.15 | $32.82 | $32.81 | +1,592% |
| November, 2027 | $30.30 | $31.41 | $31.43 | +1,495% |
| December, 2027 | $27.71 | $27.90 | $30.02 | +1,359% |
Immuneering Corp Stock (IMRX) Price Forecast for 2028
In 2028, Immuneering Corp (IMRX) is projected to reach an average price of $18.50, with a high projection of $26.96 and a low estimate of $10.05. This indicates an +873.85% rise from the last price of $1.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $27.02 | $27.23 | $26.96 | +1,322% |
| February, 2028 | $19.59 | $23.30 | $26.40 | +930.88% |
| March, 2028 | $17.42 | $18.48 | $18.19 | +816.70% |
| April, 2028 | $21.63 | $16.79 | $18.69 | +1,039% |
| May, 2028 | $22.54 | $22.20 | $21.41 | +1,087% |
| June, 2028 | $22.60 | $22.65 | $22.14 | +1,090% |
| July, 2028 | $21.17 | $21.23 | $21.52 | +1,014% |
| August, 2028 | $18.99 | $19.18 | $20.79 | +899.38% |
| September, 2028 | $12.32 | $15.37 | $17.85 | +548.67% |
| October, 2028 | $10.08 | $10.72 | $11.71 | +430.59% |
| November, 2028 | $13.55 | $11.40 | $12.43 | +613.00% |
| December, 2028 | $7.6385 | $10.05 | $11.94 | +302.03% |
Immuneering Corp Stock (IMRX) Price Forecast for 2029
The 2029 price forecast for Immuneering Corp Stock (IMRX) is $3.8865 on average, with a high prediction of $7.7268 and a low estimate of $0.0462. This represents an +104.55% increase from the previous price of $1.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.2092 | $8.2882 | $7.7268 | +279.43% |
| February, 2029 | $6.0357 | $6.6374 | $6.2334 | +217.67% |
| March, 2029 | $6.0022 | $6.1722 | $5.6472 | +215.91% |
| April, 2029 | $6.1388 | $6.4388 | $6.0905 | +223.09% |
| May, 2029 | $5.3094 | $6.7829 | $6.4812 | +179.44% |
| June, 2029 | $3.456 | $5.8137 | $5.7718 | +81.89% |
| July, 2029 | $1.9725 | $3.0183 | $2.8601 | +3.81% |
| August, 2029 | $2.5831 | $2.509 | $1.919 | +35.96% |
| September, 2029 | $0.6997 | $1.8791 | $1.7173 | -63.17% |
| October, 2029 | $0.7297 | $0.0462 | $1.8497 | -61.60% |
| November, 2029 | $2.4569 | $2.4769 | $1.9986 | +29.31% |
| December, 2029 | $2.0434 | $2.0834 | $2.041 | +7.55% |
Immuneering Corp Stock (IMRX) Price Forecast for 2030
Immuneering Corp Stock (IMRX) is expected to reach an average price of $28.14 in 2030, with a high forecast of $54.50 and a low forecast of $1.7875. This signifies an +1,381% surge from the last price of $1.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $49.29 | $1.7875 | $44.58 | +2,494% |
| February, 2030 | $50.71 | $47.90 | $46.35 | +2,569% |
| March, 2030 | $55.11 | $52.51 | $52.55 | +2,800% |
| April, 2030 | $55.00 | $54.72 | $54.20 | +2,795% |
| May, 2030 | $54.11 | $54.84 | $54.50 | +2,748% |
| June, 2030 | $52.27 | $52.41 | $52.88 | +2,651% |
| July, 2030 | $52.09 | $52.82 | $51.90 | +2,642% |
| August, 2030 | $50.59 | $51.42 | $51.55 | +2,563% |
| September, 2030 | $48.16 | $49.26 | $49.59 | +2,435% |
| October, 2030 | $44.83 | $45.16 | $47.73 | +2,259% |
| November, 2030 | $43.55 | $43.76 | $43.93 | +2,192% |
| December, 2030 | $35.52 | $39.23 | $42.78 | +1,769% |
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):